Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.
about
Endocrine and other physiologic modulators of perinatal cardiomyocyte endowmentThe autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activationMineralocorticoid receptor antagonists: emerging roles in cardiovascular medicineThe ubiquitous mineralocorticoid receptor: clinical implicationsGetting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardiumGlucocorticoid signaling in the heart: A cardiomyocyte perspectiveSimilar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signalingPrimary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Stress injuries and autophagy in mouse hippocampus after chronic cold exposure.Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.Use of phage display to identify novel mineralocorticoid receptor-interacting proteins.Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systemsMineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.The association between cortisol response to mental stress and high-sensitivity cardiac troponin T plasma concentration in healthy adults.Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive ratsGlucocorticoids Induce Cardiac Fibrosis via Mineralocorticoid Receptor in Oxidative Stress: Contribution of Elongation Factor Eleven-Nineteen Lysine-Rich Leukemia (ELL).Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia.The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathwayThe effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosteroneDiverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies.The multifaceted mineralocorticoid receptorCushing's Disease Presented by Reversible Dilated Cardiomyopathy.Serum Cortisol-to-Cortisone Ratio and Blood Pressure in Severe Obesity before and after Weight Loss.Cardiomyocyte and Vascular Smooth Muscle-Independent 11β-Hydroxysteroid Dehydrogenase 1 Amplifies Infarct Expansion, Hypertrophy, and the Development of Heart Failure After Myocardial Infarction in Male Mice.Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trialAldosterone and cardiovascular disease: the heart of the matter.The Role of Aldosterone in Obesity-Related Hypertension.Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Aldosterone, hypertension and heart failure: insights from clinical trials.The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertensionTargeting the aldosterone pathway in cardiovascular disease.Mineralocorticoid receptor antagonists for heart failure.
P2860
Q26782516-CE633EDA-7071-4735-8EE9-B925B3D3F7B4Q26826836-23FC7987-39C8-41B8-A3E1-CA46AED0664EQ26827202-CCC7ECFF-238D-4A47-A5CA-38449B6E55CAQ26861721-26499C1E-8179-4ABF-B2B4-CCBF0760DB22Q28067162-2F5A0092-9C86-4988-89C6-4A20BF7D70C6Q28083936-1AC2320D-27DE-4BFB-AFE2-96947410A90AQ28565760-04F0568D-26BE-48B6-A191-B905704BF21CQ30248429-A5B58E38-B9B5-4B18-A859-69D04D8BAF1BQ33588562-6686AC4A-85CE-4C04-A15B-4ED4E5B73D80Q33631594-9EE5631E-C83D-4F28-865B-03596A8E974BQ33631937-D6D5823F-95E9-4B53-9E26-EA382A37535FQ33660709-CF7CA54C-0D4C-46D0-9818-E17DE58235B8Q33734806-15A836F7-CE26-44F1-9D54-BDC4317729EBQ34090097-80194F11-3F82-49FD-B85E-BFB26557448EQ34354255-7EA975AD-0C84-4F19-9491-588E26B1B5CDQ34388248-583E2C8F-1817-4075-904E-55AC6DC9651CQ34403980-D66DB127-37CC-4D15-99CD-6B768FE632F2Q34591546-FFAA52D6-8302-4CB1-B94B-BDFDDB787D4CQ34989217-EA912013-B695-4A8F-890D-20170CD14D90Q34995025-AE906D27-0D4A-4BA8-8620-B3332A57054BQ35126105-B4D3AF8B-6EE1-4E57-A731-A31905896BA5Q35135164-2EF68C8C-3480-40DF-81F4-1898527806D9Q35142803-AFCC2D08-0517-4F20-A61A-D163D1189CA5Q35377605-C94735DD-B5D9-4AA0-92F9-C4F860FBCAF4Q35461760-E802B55B-653C-439D-A7BD-2329A65E13DCQ35552530-E9997559-03E1-40C5-B713-1942F1132D9AQ35906989-F6967F41-B810-4AFB-AE18-36224DD1A333Q36328858-7FE7E530-ACB5-4169-ADFB-F70E11282017Q36423063-3052030B-32BB-4DBC-9D1B-F0854026C171Q36431837-000313DF-F946-4DFA-9CE1-EF89677E411CQ36437145-861EA1FF-4B9A-4560-8F5A-0C1648C5360BQ36448508-3D844A33-6EEB-4658-BAA4-CF1BE4A5364BQ36494721-6E5331DD-161F-4B0D-A618-8DEEF1014F84Q36950174-B0D35504-976C-42A5-BA7B-8EDF664AB24CQ37580301-A4A4C008-4C82-4010-90FE-C5DCD7B29CB8Q37655884-796563DE-CC89-4221-B44B-701BFFEBD88FQ37772759-35684755-2699-466A-96CA-4B5F56CF0EB1Q37826130-AB1C3CC9-6AA5-423B-B8B8-1CBADF0E137DQ37951665-28E09061-2ECF-436B-ABF3-6102123EF7BCQ37955919-E613BB20-CC6C-4A6E-947A-5C9FD509BA4D
P2860
Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Glucocorticoids activate cardi ...... imental myocardial infarction.
@en
Glucocorticoids activate cardi ...... imental myocardial infarction.
@nl
type
label
Glucocorticoids activate cardi ...... imental myocardial infarction.
@en
Glucocorticoids activate cardi ...... imental myocardial infarction.
@nl
prefLabel
Glucocorticoids activate cardi ...... imental myocardial infarction.
@en
Glucocorticoids activate cardi ...... imental myocardial infarction.
@nl
P2093
P1433
P1476
Glucocorticoids activate cardi ...... imental myocardial infarction.
@en
P2093
John W Funder
Mahidi Mardini
Thi Yen Loan Le
P304
P356
10.1161/HYPERTENSIONAHA.109.136242
P407
P577
2009-10-19T00:00:00Z